United Therapeutics Corp
UTHR· Nasdaq
Released Oct 29, 2025, before the open
10-Q filed Oct 29, 2025, 29 days after period end · 0001082554-25-000034
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $799.50M | $748.90M | $609.40M | $516.00M |
| Net Income | $338.70M | $309.10M | $267.60M | $239.30M |
| EPS Diluted |
United Therapeutics Corp · CIK 1082554 · Engraved from SEC EDGAR
| $7.16 |
| $6.39 |
| $5.38 |
| $4.91 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.